Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

431 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Completed

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT03092674

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 506 locations
View Trial Details
Completed

The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

NCT01566695

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • Tower Hematology/Oncology Medical Group and Tower Cancer Research Found Beverly Hills, California, United States
  • City Of Hope Duarte, California, United States
  • California Cancer Associates for Research and Excellence cCARE Escondido, California, United States
View all 196 locations
View Trial Details
Completed

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

NCT04079296

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • City of Hope Duarte, California, United States
  • Memorial Healthcare System-West Pembroke Pines, Florida, United States
  • NYU Langone Health New York, United States
  • Site JP81005 Nagoya, Aichi-ken, Japan
View all 16 locations
View Trial Details
Completed

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +37 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of South Florida Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS)

NCT02103478

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Horizon Oncology Lafayette, Indiana, United States
View all 17 locations
View Trial Details
Completed

Decitabine Versus Supportive Care in Adults With Advanced-stage MDS

NCT00043381

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Scripps Clinic Escondido, California, United States
  • Loma Linda Univ. Cancer Center Loma Linda, California, United States
View all 24 locations
View Trial Details

Related conditions